id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2007-D-0309-0001,FDA,FDA-2007-D-0309,Drug-Induced Liver Injury; Premarketing Clinical Evaluation; Draft Guidance,Notice,NAD-Notice of Availability of Data,2007-10-25T04:00:00Z,2007,10,2007-10-25T04:00:00Z,2007-12-25T04:59:59Z,2008-08-27T17:27:07Z,72FR60681,0,0,090000648042b6c1
FDA-2007-D-0309-0002,FDA,FDA-2007-D-0309,Drug-Induced Liver Injury: Premarketing Clinical Evaluation Draft Guidance,Supporting & Related Material,GDL-Guidance,2007-10-25T04:00:00Z,2007,10,,,2008-08-27T17:31:12Z,,0,0,090000648042b6c2